Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Ayaan Ahmed Qureshi
Institution:
Liaquat National Hospital
Observed institution:
Liaquat National Hospital
ORCID:
0009-0007-9148-8599
Observed ORCID:
0009-0007-9148-8599
OpenAlex ID:
A5000207572
‘Tarlatamab’s FDA approval: shaping the future of cancer therapy’
2024
·
Iqra Alamgir
, Unsa Alamgir
, et al.
·
Annals of Medicine and Surgery
·
7
‘Lenmeldy (OTL-200) in MLD: FDA’s validation of advanced therapy’
2024
·
Ayaan Ahmed Qureshi
, Bakhtawar Shaikh
, et al.
·
Annals of Medicine and Surgery
·
5
Aldosterone synthase inhibitor “Baxdrostat” for resistant hypertension: A clinical approach or futuristic idea?
2023
·
Muhammad Osama Siddiqui
, Ayaan Ahmed Qureshi
, et al.
·
Chronic Diseases and Translational Medicine
·
3
PDF
Risk Factors and Pharmacological Interventions Impacting Cerebrovascular Ischemic Events in Giant Cell Arteritis: A Narrative Review
2025
·
Muhammad Osama Siddiqui
, Mohammad Ali Syed
, et al.
·
Immunity Inflammation and Disease
·
1
PDF
Diagnostic challenges and management of kikuchi-fujimoto disease: a rare case report
2024
·
Jatin Motwani
, Ameet Kumar
, et al.
·
Annals of Medicine and Surgery
·
1
Comment on: Ketamine use for management of vaso‐occlusive pain in pediatric sickle cell disease
2023
·
Ayaan Ahmed Qureshi
·
Pediatric Blood & Cancer
·
1
“Breaking Ground: Lenmeldy’s Approval and the Future of MLD Treatment”
2024
·
Ayaan Ahmed Qureshi
, Aishath Sadha Aswad
, et al.
Show more works
View as search
Works count:
7
Citation count:
18
H-index:
3
I10-index:
Year
Topic
Type